AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteArtemether has been shown to have significant anticancer and antitumor activities. It is demonstrated that artemether caused strong inhibitory effects on brain glioma growth and angiogenesis in rats.
More Information Supplier PageArtemether has been shown to have significant anticancer and antitumor activities. It is demonstrated that artemether caused strong inhibitory effects on brain glioma growth and angiogenesis in rats.
More Information Supplier PageArtemether has been shown to have significant anticancer and antitumor activities. It is demonstrated that artemether caused strong inhibitory effects on brain glioma growth and angiogenesis in rats.
More Information Supplier PageArtemisinin and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria.
More Information Supplier PageArtemisinin and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria.
More Information Supplier PageArtemisinin and its derivatives are a group of drugs that possess the most rapid action of all current drugs against Plasmodium falciparum malaria.
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArtesunate is a semisynthetic derivative of artemisinin used to treat malaria. It has also been shown to effective against other parasites such as liver flukes. Artesunate also demonstrates cytotoxic action against cancer cell lines of different tumor types. Artesunate has been shown to inhibit TNF–induced production of proinflammatory cytokines via inhibition of NF-B and PI3 […]
More Information Supplier PageArticaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information Supplier PageArticaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information Supplier PageArticaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information Supplier PageArticaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information Supplier PageArticaine is a dental local anesthetic which contains an additional ester group that is metabolized by estearases in blood and tissue.
More Information Supplier PageArzoxifene HCl is the hydrochloride salt of arzoxifene, a synthetic aromatic derivative with anti-estrogenic properties. Arzoxifene binds to estrogen receptors as a mixed estrogen agonist/antagonist.
More Information Supplier PageArzoxifene HCl is the hydrochloride salt of arzoxifene, a synthetic aromatic derivative with anti-estrogenic properties. Arzoxifene binds to estrogen receptors as a mixed estrogen agonist/antagonist.
More Information Supplier PageArzoxifene HCl is the hydrochloride salt of arzoxifene, a synthetic aromatic derivative with anti-estrogenic properties. Arzoxifene binds to estrogen receptors as a mixed estrogen agonist/antagonist.
More Information Supplier PageAS-252424 is a potent inhibitor of PI3K with selectivity for the ?? isoform. It inhibits human recombinant PI3K??, ??, ??, and ?? with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.
More Information Supplier PageAS-252424 is a potent inhibitor of PI3K with selectivity for the ?? isoform. It inhibits human recombinant PI3K??, ??, ??, and ?? with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.
More Information Supplier PageAS-252424 is a potent inhibitor of PI3K with selectivity for the ?? isoform. It inhibits human recombinant PI3K??, ??, ??, and ?? with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.
More Information Supplier PageAS-252424 is a potent inhibitor of PI3K with selectivity for the ?? isoform. It inhibits human recombinant PI3K??, ??, ??, and ?? with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.
More Information Supplier PageAS-252424 is a potent inhibitor of PI3K with selectivity for the ?? isoform. It inhibits human recombinant PI3K??, ??, ??, and ?? with IC50 values of 30, 940, 20,000, and 20,000 nM respectively.
More Information Supplier PageAS-604850 inhibited MCP-1-mediated monocyte chemotaxis with an IC50 value of 21 µM and reduced RANTES-induced peritoneal neutrophil recruitment in a murine model of leukocyte chemotaxis with an ED50 value of 42.4 mg/kg.
More Information Supplier PageAS-604850 inhibited MCP-1-mediated monocyte chemotaxis with an IC50 value of 21 µM and reduced RANTES-induced peritoneal neutrophil recruitment in a murine model of leukocyte chemotaxis with an ED50 value of 42.4 mg/kg.
More Information Supplier PageAS-604850 inhibited MCP-1-mediated monocyte chemotaxis with an IC50 value of 21 µM and reduced RANTES-induced peritoneal neutrophil recruitment in a murine model of leukocyte chemotaxis with an ED50 value of 42.4 mg/kg.
More Information Supplier PageAS-604850 inhibited MCP-1-mediated monocyte chemotaxis with an IC50 value of 21 µM and reduced RANTES-induced peritoneal neutrophil recruitment in a murine model of leukocyte chemotaxis with an ED50 value of 42.4 mg/kg.
More Information Supplier PageAS-604850 inhibited MCP-1-mediated monocyte chemotaxis with an IC50 value of 21 µM and reduced RANTES-induced peritoneal neutrophil recruitment in a murine model of leukocyte chemotaxis with an ED50 value of 42.4 mg/kg.
More Information Supplier PageAS-605240 is an orally active inhibitor of PI3-kinase ?? that inhibits human recombinant PI3K??, ??, ??, and ?? in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.
More Information Supplier PageAS-605240 is an orally active inhibitor of PI3-kinase ?? that inhibits human recombinant PI3K??, ??, ??, and ?? in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.
More Information Supplier PageAS-605240 is an orally active inhibitor of PI3-kinase ?? that inhibits human recombinant PI3K??, ??, ??, and ?? in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.
More Information Supplier PageAS-605240 is an orally active inhibitor of PI3-kinase ?? that inhibits human recombinant PI3K??, ??, ??, and ?? in an ATP-competitive manner with IC50 values of 8, 60, 270, and 300 nM, respectively.
More Information Supplier PageAS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor that inhibits growth and survival of MM cells and cytokine-induced osteoclast differentiation.
More Information Supplier PageAS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor that inhibits growth and survival of MM cells and cytokine-induced osteoclast differentiation.
More Information Supplier PageAS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor that inhibits growth and survival of MM cells and cytokine-induced osteoclast differentiation.
More Information Supplier PageAS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor that inhibits growth and survival of MM cells and cytokine-induced osteoclast differentiation.
More Information Supplier PageAS703026 is a novel, selective, orally bioavailable MEK1/2 inhibitor that inhibits growth and survival of MM cells and cytokine-induced osteoclast differentiation.
More Information Supplier PageAsarinin was isolated from the radix of Asiasarum heterotropoides var.
More Information Supplier PageAsarinin was isolated from the radix of Asiasarum heterotropoides var.
More Information Supplier PageAsarinin was isolated from the radix of Asiasarum heterotropoides var.
More Information Supplier PageASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors.
More Information Supplier Page
